Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2011-04-26 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-VIATRE (41210), Loir-et-Cher
PHARMACIE DES ETANGS : revenue, balance sheet and financial ratios
PHARMACIE DES ETANGS is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-VIATRE (41210),
this company of category PME
shows in 2023 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES ETANGS (SIREN 531943314)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 283 744 €
1 395 433 €
1 225 217 €
1 242 377 €
1 197 890 €
1 178 459 €
1 017 480 €
1 044 558 €
Net income
97 057 €
85 285 €
124 412 €
116 659 €
103 707 €
103 435 €
110 928 €
106 016 €
109 688 €
EBITDA
N/C
118 170 €
165 474 €
153 238 €
142 944 €
151 033 €
154 621 €
152 449 €
166 469 €
Net margin
N/C
6.6%
8.9%
9.5%
8.3%
8.6%
9.4%
10.4%
10.5%
Revenue and income statement
In 2024, PHARMACIE DES ETANGS generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 110 k€ -> 97 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
97 057 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 94%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.044%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
94.302%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES ETANGS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
85.025
62.496
44.698
32.726
22.751
14.075
6.669
1.314
1.044
Financial autonomy
50.457
56.599
65.969
71.505
77.448
82.721
89.319
94.55
94.302
Repayment capacity
4.648
4.097
3.196
2.546
2.091
1.312
0.638
0.165
None
Cash flow / Revenue
10.827%
10.715%
9.671%
9.725%
8.729%
9.625%
9.101%
7.641%
None%
Sector positioning
Debt ratio
1.042024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE DES ETANGS (1.04) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
94.3%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES ETANGS (94.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.17 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DES ETANGS (0.17) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 607.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
607.321
Liquidity indicators evolution PHARMACIE DES ETANGS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
375.992
332.935
541.575
531.475
582.449
556.022
638.787
642.523
607.321
Interest coverage
8.074
6.01
4.558
2.921
2.308
1.455
0.691
0.135
None
Sector positioning
Liquidity ratio
607.322024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE DES ETANGS (607.32) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.14x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DES ETANGS (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES ETANGS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
224 005 €
232 901 €
236 540 €
261 224 €
284 678 €
227 964 €
222 990 €
228 378 €
0 €
Inventory turnover (days)
33
35
29
29
31
33
28
31
0
Customer payment term (days)
5
4
3
3
3
5
4
7
0
Supplier payment term (days)
31
40
17
22
21
24
17
15
0
Positioning of PHARMACIE DES ETANGS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES ETANGS is estimated at
1 354 987 €
(range 943 591€ - 2 027 138€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
943k€1354k€2027k€
1 354 987 €Range: 943 591€ - 2 027 138€
NAF 5 année 2024
Valuation method used
Net Income Multiple
97 057 €
×
14.0x
=1 354 987 €
Range: 943 592€ - 2 027 139€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES ETANGS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES ETANGS
What is the revenue of PHARMACIE DES ETANGS ?
The revenue of PHARMACIE DES ETANGS in 2023 is 1.3 M€.
Is PHARMACIE DES ETANGS profitable?
Yes, PHARMACIE DES ETANGS generated a net profit of 97 k€ in 2024.
Where is the headquarters of PHARMACIE DES ETANGS ?
The headquarters of PHARMACIE DES ETANGS is located in SAINT-VIATRE (41210), in the department Loir-et-Cher.
Where to find the tax return of PHARMACIE DES ETANGS ?
The tax return of PHARMACIE DES ETANGS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES ETANGS operate?
PHARMACIE DES ETANGS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart